New to Bioss? Enjoy 35% of your first order. Use code "FirstOrder35" - Offer valid for new U.S. Customers on direct orders only

phospho-IRS1 (Tyr632) Polyclonal Antibody, Cy7 Conjugated

Applications

  • FCM

Reactivity

  • Human
  • Mouse
  • Rat
  • Bovine
  • Dog
  • Pig
  • Sheep
  • Rabbit
Overview
Catalog # bs-8707R-Cy7
Product Name phospho-IRS1 (Tyr632) Polyclonal Antibody, Cy7 Conjugated
Applications FCM
Reactivity Human, Mouse, Rat, Bovine, Dog, Pig, Sheep, Rabbit
Specifications
Conjugation Cy7
Host Rabbit
Source KLH conjugated Synthesised phosphopeptide derived from human IRS1 around the phosphorylation site of Tyr632
Modification Site Tyr632
Clonality Polyclonal
Isotype IgG
Concentration 1ug/ul
Purification Purified by Protein A.
Storage Buffer Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Storage Condition Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Target
Gene ID 3667
Swiss Prot P35568
Subcellular location Cell membrane
Synonyms IRS1 (phospho Tyr632); IRS1 (phospho Y632); p-IRS1 (phospho Y632); HIRS 1; HIRS1; Insulin Receptor Substrate 1; IRS 1; IRS-1; IRS1; IRS1_HUMAN; OTTHUMP00000164234.
Background Insulin receptor substrates (IRS) are responsible for several insulin related activities, such as glucose homeostasis, cell growth, cell transformation, apoptosis and insulin signal transduction. Serine/threonine phosphorylation of IRS1 has been demonstrated to be a negative regulator of insulin signaling and is responsible for its degradation, although IRS1 degradation pathways are not well understood. IRS1 has also been shown to be constitutively activated in cancers such as breast cancer, Wilm's tumors, and adrenal cortical carcinomas, thus making IRS1 phosphorylation and subsequent degradation an attractive therapeutic target. To date there have been four subtypes identified: IRS1, 2, 3 and 4, with IRS1 being widely expressed.
Application Dilution
FCM 1:20-100